Wednesday, May 01, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Guillain-Barré Syndrome Linked to the RSV Vaccine

paralysis in the arm

The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]

Doctors Link Shortage of Children’s Medications to Spike in Respiratory Infections

boy being examined by doctor

In the last few months, parents and caregivers of children have struggled to find over-the-counter and prescription medications used to treat common childhood illnesses like influenza, ear infections and sore throats for their sick children.1 2 The four medications reportedly in short supply are Amoxicillin (an antibiotic), Tamiflu (an antiviral), Albuterol (a bronchodilator) and children’s Tylenol […]

RSV Cases Could Be a Long-Term Consequence of COVID Vaccination

RSV Cases Could Be a Long-Term Consequence of COVID Vaccination

Many people believe that immunities have been suppressed, that people’s immune systems have been suppressed because of the [COVID-19] vaccine. Do you think that that is contributing to the situation with RSV? I do, and a lot of doctors believe in the concept of immunity death, that is when you’re virus naive a long period […]

Pfizer’s New RSV Vaccine for Pregnant Women on Fast Track

pregnant mother holding belly

Amongst frantic media coverage of increases in cases of (RSV) among children, Pfizer has announced the development of an experimental bivalent RSV vaccine for pregnant mothers in an attempt to protect newborns from being infected with the virus. The pharmaceutical giant plans to submit the results of their RSV vaccine clinical trials to the U.S. […]

Johnson & Johnson Fined $572 Million for “Greed” in Fueling the Opioid Crisis

drug overdose

In a lawsuit filed by the state of Oklahoma against Johnson & Johnson, Inc., Purdue Pharma LP and Teva Pharmaceutical Industries Ltd., the pharmaceutical giant Johnson & Johnson and its subsidiaries were ordered on Aug. 26, 2019 to pay $572 million in penalties for helping to fuel the opioid crisis in Oklahoma.1 Before the trial […]

Search in Site

To search in site, type your keyword and hit enter

Search